Multifunctional Substrate for Early Detection of Oxidative Stress Susceptibility and Application to Parkinson's Disease

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00271141

Enrollment

500

Registered

2005-12-30

Start date

2005-05-31

Completion date

2015-12-31

Last updated

2005-12-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oxidative Stress, Parkinson's Disease

Keywords

Parkinson's disease, Oxidative stress, Marker

Brief summary

The proposed work is based on the detection of a novel molecule for sensitivity to oxidative stress in humans in venous blood

Detailed description

Since alterations in mitochondrial functions in platelets and lymphocytes have been detected in Parkinson's disease we plan to monitor the metabolism a a new molecule (LTG) in the blood samples of Parkinson's disease patients and compare them to controls. We shall use 10 cc of venous blood and analyze serum, white blood cells and platelets. We shall not extract nor use DNA.The main purpose is to develop a marker for Parkinson's disease in venous blood.

Interventions

None listed

Study design

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

Parkinson's disease Healthy control -

Exclusion criteria

None -

Countries

Israel

Contacts

Primary ContactRivka Inzelberg, MD

inzelberg@hy.health.gov.il+972-4-6304607

Outcome results